Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Kidney Disease Stage 2”

352 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 352 results

Large-scale testing (Phase 3)Looking for participantsNCT06982079
What this trial is testing

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Stage 5CKD Stage 4
Ain Shams University 60
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06751602
What this trial is testing

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Rejection Chronic Renal
The Methodist Hospital Research Institute 40
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04551300
What this trial is testing

Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients

Who this might be right for
Hyperphosphatemia
Shanghai Alebund Pharmaceuticals Limited 158
Large-scale testing (Phase 3)UnknownNCT03831464
What this trial is testing

Metformin as RenoProtector of Progressive Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Universiteit Antwerpen 290
Not applicableUnknownNCT03082365
What this trial is testing

Oral Findings in Chronic Kidney Disease

Who this might be right for
Oral DiseaseChronic Kidney Diseases
Maryam Ahmed Essam Abdel Salam 225
Large-scale testing (Phase 3)WithdrawnNCT05286853
What this trial is testing

Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Diseases
Prokidney
Testing effectiveness (Phase 2)Active Not RecruitingNCT06942910
What this trial is testing

Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria

Who this might be right for
Chronic Kidney Disease With High Proteinuria
AstraZeneca 224
Not applicableNot Yet RecruitingNCT06650215
What this trial is testing

The 2-minute Walk Test in Hemodialysis Patients

Who this might be right for
End Stage Renal Disease
Kirsehir Ahi Evran Universitesi 36
Large-scale testing (Phase 3)Study completedNCT02780141
What this trial is testing

Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia

Who this might be right for
ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc 75
Testing effectiveness (Phase 2)Looking for participantsNCT07783802
What this trial is testing

Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Who this might be right for
AtherosclerosisCardiovascular DiseaseObesity+3 more
Eli Lilly and Company 120
Testing effectiveness (Phase 2)Study completedNCT03270956
What this trial is testing

Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Prokidney 10
Post-approval studies (Phase 4)Study completedNCT04575896
What this trial is testing

Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors

Who this might be right for
End Stage Renal DiseaseHepatitis C
Johns Hopkins University 10
Not applicableStudy completedNCT07718880
What this trial is testing

Nephroprotective Effects of Fig (Ficus Carica L.) Leaf Supplementation

Who this might be right for
Diabete MellitusDiabetic Nephropathy
University of Lahore 60
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Ended earlyNCT03140722
What this trial is testing

Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 2
Testing effectiveness (Phase 2)Study completedNCT05216172
What this trial is testing

AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce

Who this might be right for
Type 2 DiabetesDiabetes Mellitus, Type 2Renal Transplant+2 more
Queen Mary University of London 26
Testing effectiveness (Phase 2)Study completedNCT02260193
What this trial is testing

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

Who this might be right for
AnemiaEnd Stage Renal Disease
Akebia Therapeutics 94
Large-scale testing (Phase 3)Active Not RecruitingNCT06087835
What this trial is testing

Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

Who this might be right for
Chronic Kidney Disease With High Proteinuria
AstraZeneca 1,835
Next Page